Loading clinical trials...
Loading clinical trials...
An Open-label Study of MabThera on Objective Overall Tumor Response in Treatment-naïve Patients With Non-bulky Follicular Non-Hodgkin's Lymphoma
Conditions
Interventions
rituximab [MabThera/Rituxan]
Locations
16
France
Angers, France
Besançon, France
Bordeaux, France
Clamart, France
Créteil, France
Le Mans, France
Start Date
October 1, 1997
Primary Completion Date
February 1, 2006
Completion Date
February 1, 2006
Last Updated
November 2, 2016
NCT06667687
NCT05623982
NCT03314974
NCT04586478
NCT05054257
NCT01746849
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions